Baxter Sues Talecris Over Blood Test Patents
Baxter filed suit Wednesday in the U.S. District Court for the Eastern District of North Carolina along with the National Genetics Institute, a subsidiary of Laboratory Corporation of America Holdings that holds a license on the patents. NGI provides blood testing services for HIV, hepatitis and other infections, according to the complaint.
One patent-in-suit, U.S. Patent Number 5,780,222, which was issued in 1998, describes...
To view the full article, register now.